Home > PS Ratio > IPCA LABORATORIES

IPCA LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of IPCA LABORATORIES is 5.10.

Share Price ₹1,649.4Oct 17,2024
Market Cap ₹41,844.0 Cr
Sales-TTM₹8,212.5 CrTTM-Consolidated Results
Price/Sales5.10xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of IPCA LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of IPCA LABORATORIES is calculated as :

Current Market Cap [ ₹41,844.0 Cr] as on Oct 17,2024

(/) Sales [ ₹8,212.5 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 5.10x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for IPCA LABORATORIES , the investors are currently willing to pay '5.10 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of IPCA LABORATORIES !

The chart below summarizes the trend in P/S Ratio of IPCA LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of IPCA LABORATORIES


PS Ratio Performance Analysis for IPCA LABORATORIES

- IPCA LABORATORIES 's latest p/e ratio is 5.10x.

- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 4.06x.

- IPCA LABORATORIES 's operated at median p/e ratio of 4.1x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2022 at 4.64x.

- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 3.31x.


How does IPCA LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
IPCA LABORATORIES 8,212.55.1041,844.0
SUN PHARMACEUTICAL INDUSTRIES LTD49,208.89.22453,486.0
CIPLA LTD26,139.14.81125,852.0
DR REDDYS LABORATORIES LTD28,949.33.86111,799.0
ZYDUS LIFESCIENCES LTD20,615.34.98102,726.0
DIVIS LABORATORIES LTD8,185.019.71161,321.0
MANKIND PHARMA LTD10,649.610.09107,467.0
TORRENT PHARMACEUTICALS LTD10,996.010.45114,943.0
LUPIN LTD20,797.14.7799,304.7
AUROBINDO PHARMA LTD29,718.42.8785,273.3
ABBOTT INDIA LTD5,927.510.1960,382.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs IPCA LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.87x
Max industry PS 19.71x
Median industry PS 5.10x
Average industry PS 7.82x



You may also like the below Video Courses